JPMorgan Chase & Co. has filed a major holdings notification disclosing a combined voting interest of 7.991397% in Bodycote plc (BOY), the UK-listed heat treatment and thermal processing specialist. The threshold was crossed on 17 November 2026, with the issuer notified on 19 November 2026. The position is held through a combination of direct shares and an extensive portfolio of cash-settled equity swaps, representing a total of 13,600,398 voting rights in the company.

Key Points

  • Bodycote plc (BOY) — UK-listed thermal processing and heat treatment group
  • JPMorgan Chase & Co. has disclosed a combined voting interest of 7.991397% following a threshold crossing on 17 November 2026
  • Total position comprises 0.620854% in direct shares and 7.370543% through cash-settled financial instruments; previous total was 8.015325%
  • Investors may watch whether JPMorgan's aggregate position changes further, given the slight reduction from the prior notification

JPMorgan's Combined Position in Bodycote Falls Slightly From Previous Notification Level

According to the TR-1 filing, JPMorgan Chase & Co.'s total combined voting interest in Bodycote plc stands at 7.991397%, a modest reduction from the previously notified position of 8.015325%. The direct shareholding held through J.P. Morgan Securities PLC amounts to 1,056,619 shares, equating to 0.620854% of voting rights. This direct component also decreased slightly from the prior notification figure of 0.660713%, whilst the financial instruments component increased marginally from 7.354612% to 7.370543%, reflecting ongoing activity across JPMorgan's trading and hedging operations.

Nineteen Cash-Settled Equity Swaps Underpin the Majority of JPMorgan's Bodycote Exposure

The bulk of JPMorgan's voting interest in Bodycote is held indirectly through nineteen separate cash-settled equity swap contracts, collectively representing 12,543,779 voting rights or 7.370543% of the company's total. These instruments carry expiry dates ranging from 15 December 2026 through to 21 December 2028, with the largest individual positions including a swap expiring 30 April 2027 covering 2,729,025 voting rights and a swap expiring 16 June 2027 covering 2,367,294 voting rights. All swaps are classified as cash-settled, meaning they do not necessarily confer an obligation to acquire the underlying shares.

J.P. Morgan Securities PLC Acts as Shareholder Within JPMorgan Chase's Controlled Undertaking Chain

The filing sets out a detailed chain of controlled undertakings beneath JPMorgan Chase & Co. as ultimate controlling entity. J.P. Morgan Securities PLC, which holds the direct share position, sits beneath JPMorgan Chase Bank, National Association, J.P. Morgan International Finance Limited, and J.P. Morgan Capital Holdings Limited, each owned at 100%. Additional group entities named in the notification include J.P. Morgan SE and J.P. Morgan Markets Limited, though their individual voting rights did not independently meet notifiable thresholds in this disclosure. The notification was completed in London on 19 November 2026.

Bodycote's Position as a UK Industrial Specialist Draws Institutional Attention

Bodycote plc operates as one of the world's largest providers of heat treatment and specialist thermal processing services, supplying industries including aerospace, automotive, and energy. The company is incorporated in the UK under ISIN GB00B3FLWH99. Institutional disclosures of this nature, filed under DTR5 obligations, are a standard regulatory requirement when investors cross or fall below prescribed voting rights thresholds. Investors may watch subsequent TR-1 filings to assess whether JPMorgan's aggregate exposure to Bodycote continues to change materially in the coming months.